Plasma catecholamines, including epinephrine and norepinephrine, are critical stress response mediators.
Morphine's effects on catecholamine levels are complex and not fully understood.
Previous research indicates variable responses to opioid administration.
Purpose of the Study:
To investigate the dose-dependent and condition-specific effects of morphine on plasma catecholamine levels in dogs.
To elucidate the mechanisms underlying morphine's influence on epinephrine and norepinephrine.
To differentiate between the analgesic and central nervous system effects of morphine on catecholamine release.
Main Methods:
Administering different doses of morphine (30 mg s.c. vs. 15 mg i.v.) to conscious and anesthetized dogs.
Utilizing laparotomy as a variable experimental condition in anesthetized dogs.
Measuring plasma concentrations of epinephrine and norepinephrine under various experimental conditions.
Main Results:
In conscious dogs, subcutaneous morphine (30 mg) significantly elevated plasma epinephrine but not norepinephrine.
In anesthetized, laparotomized dogs, intravenous morphine (15 mg) attenuated the rise in both plasma epinephrine and norepinephrine.
No significant changes in plasma catecholamines were observed with either morphine dose in non-laparotomized, anesthetized dogs.
Conclusions:
Morphine's effect on plasma catecholamines is highly dependent on dosage and experimental context.
The catecholamine-lowering effect of morphine appears linked to its analgesic properties.
The catecholamine-elevating effect may result from the activation of specific central nervous system pathways, which are inhibited by barbiturate anesthesia.